nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP2D6—breast cancer	0.144	0.538	CbGaD
Paliperidone—CYP3A4—breast cancer	0.124	0.462	CbGaD
Paliperidone—CYP3A5—Lapatinib—breast cancer	0.0342	0.0996	CbGbCtD
Paliperidone—CYP3A4—Exemestane—breast cancer	0.0264	0.0768	CbGbCtD
Paliperidone—CYP2D6—Idarubicin—breast cancer	0.0238	0.0693	CbGbCtD
Paliperidone—CYP3A4—Letrozole—breast cancer	0.0224	0.0653	CbGbCtD
Paliperidone—CYP3A4—Anastrozole—breast cancer	0.02	0.0582	CbGbCtD
Paliperidone—CYP3A4—Toremifene—breast cancer	0.0183	0.0532	CbGbCtD
Paliperidone—CYP3A5—Tamoxifen—breast cancer	0.0171	0.0498	CbGbCtD
Paliperidone—CYP3A4—Fulvestrant—breast cancer	0.017	0.0495	CbGbCtD
Paliperidone—CYP3A4—Thiotepa—breast cancer	0.0152	0.0441	CbGbCtD
Paliperidone—CYP3A4—Ixabepilone—breast cancer	0.0139	0.0403	CbGbCtD
Paliperidone—CYP3A4—Lapatinib—breast cancer	0.0133	0.0388	CbGbCtD
Paliperidone—CYP3A5—Paclitaxel—breast cancer	0.0133	0.0388	CbGbCtD
Paliperidone—CYP3A5—Irinotecan—breast cancer	0.0132	0.0383	CbGbCtD
Paliperidone—CYP2D6—Vinorelbine—breast cancer	0.0116	0.0339	CbGbCtD
Paliperidone—CYP2D6—Tamoxifen—breast cancer	0.0105	0.0306	CbGbCtD
Paliperidone—CYP3A4—Raloxifene—breast cancer	0.0101	0.0294	CbGbCtD
Paliperidone—CYP3A5—Docetaxel—breast cancer	0.00964	0.0281	CbGbCtD
Paliperidone—CYP3A4—Vinorelbine—breast cancer	0.0074	0.0215	CbGbCtD
Paliperidone—CYP2D6—Vinblastine—breast cancer	0.00717	0.0209	CbGbCtD
Paliperidone—CYP3A4—Tamoxifen—breast cancer	0.00668	0.0194	CbGbCtD
Paliperidone—CYP3A4—Mitoxantrone—breast cancer	0.00651	0.019	CbGbCtD
Paliperidone—CYP3A4—Paclitaxel—breast cancer	0.0052	0.0151	CbGbCtD
Paliperidone—CYP3A4—Irinotecan—breast cancer	0.00513	0.0149	CbGbCtD
Paliperidone—CYP3A4—Vinblastine—breast cancer	0.00456	0.0133	CbGbCtD
Paliperidone—CYP2D6—Doxorubicin—breast cancer	0.00441	0.0128	CbGbCtD
Paliperidone—CYP3A4—Docetaxel—breast cancer	0.00376	0.0109	CbGbCtD
Paliperidone—CYP3A4—Doxorubicin—breast cancer	0.0028	0.00815	CbGbCtD
Paliperidone—Risperidone—CYP2D6—breast cancer	0.000455	0.232	CrCbGaD
Paliperidone—Iloperidone—CYP2D6—breast cancer	0.000426	0.217	CrCbGaD
Paliperidone—Risperidone—CYP3A4—breast cancer	0.00039	0.199	CrCbGaD
Paliperidone—Iloperidone—CYP3A4—breast cancer	0.000366	0.187	CrCbGaD
Paliperidone—Risperidone—ABCB1—breast cancer	0.000325	0.166	CrCbGaD
Paliperidone—ADRA2C—nipple—breast cancer	0.000132	0.0404	CbGeAlD
Paliperidone—HRH1—nipple—breast cancer	0.000108	0.0328	CbGeAlD
Paliperidone—ADRA2A—nipple—breast cancer	0.000106	0.0322	CbGeAlD
Paliperidone—ADRA1A—epithelium—breast cancer	9.35e-05	0.0286	CbGeAlD
Paliperidone—HTR1B—female reproductive system—breast cancer	9.34e-05	0.0285	CbGeAlD
Paliperidone—HTR1D—female reproductive system—breast cancer	9.04e-05	0.0276	CbGeAlD
Paliperidone—HTR2C—female reproductive system—breast cancer	8.95e-05	0.0273	CbGeAlD
Paliperidone—ADRA2C—endometrium—breast cancer	7.99e-05	0.0244	CbGeAlD
Paliperidone—HTR1B—endocrine gland—breast cancer	7.9e-05	0.0241	CbGeAlD
Paliperidone—ADRA1A—adipose tissue—breast cancer	7.56e-05	0.0231	CbGeAlD
Paliperidone—DRD2—pituitary gland—breast cancer	7.44e-05	0.0227	CbGeAlD
Paliperidone—HTR2A—embryo—breast cancer	7.41e-05	0.0226	CbGeAlD
Paliperidone—ADRA2C—uterus—breast cancer	7.36e-05	0.0225	CbGeAlD
Paliperidone—HTR1A—adrenal gland—breast cancer	7.35e-05	0.0225	CbGeAlD
Paliperidone—HRH1—epithelium—breast cancer	7.24e-05	0.0221	CbGeAlD
Paliperidone—ADRA2C—pituitary gland—breast cancer	7.23e-05	0.0221	CbGeAlD
Paliperidone—ADRA2C—adipose tissue—breast cancer	7.2e-05	0.022	CbGeAlD
Paliperidone—ADRA1A—adrenal gland—breast cancer	6.78e-05	0.0207	CbGeAlD
Paliperidone—HRH1—endometrium—breast cancer	6.49e-05	0.0198	CbGeAlD
Paliperidone—ADRA2C—adrenal gland—breast cancer	6.46e-05	0.0197	CbGeAlD
Paliperidone—HTR1A—endocrine gland—breast cancer	6.38e-05	0.0195	CbGeAlD
Paliperidone—ADRA2A—endometrium—breast cancer	6.38e-05	0.0195	CbGeAlD
Paliperidone—HTR2A—epithelium—breast cancer	6.05e-05	0.0185	CbGeAlD
Paliperidone—CYP3A5—adipose tissue—breast cancer	6.03e-05	0.0184	CbGeAlD
Paliperidone—ADRA2C—female gonad—breast cancer	6.02e-05	0.0184	CbGeAlD
Paliperidone—ADRA1A—endocrine gland—breast cancer	5.88e-05	0.018	CbGeAlD
Paliperidone—ADRA2A—uterus—breast cancer	5.88e-05	0.0179	CbGeAlD
Paliperidone—HRH1—adipose tissue—breast cancer	5.85e-05	0.0179	CbGeAlD
Paliperidone—ADRA2A—pituitary gland—breast cancer	5.77e-05	0.0176	CbGeAlD
Paliperidone—DRD2—endocrine gland—breast cancer	5.76e-05	0.0176	CbGeAlD
Paliperidone—ADRA2A—adipose tissue—breast cancer	5.75e-05	0.0175	CbGeAlD
Paliperidone—HRH1—female reproductive system—breast cancer	5.38e-05	0.0164	CbGeAlD
Paliperidone—ADRA2A—female reproductive system—breast cancer	5.28e-05	0.0161	CbGeAlD
Paliperidone—HRH1—adrenal gland—breast cancer	5.25e-05	0.016	CbGeAlD
Paliperidone—ADRA2A—adrenal gland—breast cancer	5.15e-05	0.0157	CbGeAlD
Paliperidone—CYP3A5—female gonad—breast cancer	5.04e-05	0.0154	CbGeAlD
Paliperidone—HTR2A—pituitary gland—breast cancer	4.91e-05	0.015	CbGeAlD
Paliperidone—HRH1—female gonad—breast cancer	4.89e-05	0.0149	CbGeAlD
Paliperidone—ADRA2A—female gonad—breast cancer	4.81e-05	0.0147	CbGeAlD
Paliperidone—CYP3A5—endocrine gland—breast cancer	4.69e-05	0.0143	CbGeAlD
Paliperidone—HRH1—endocrine gland—breast cancer	4.55e-05	0.0139	CbGeAlD
Paliperidone—HTR2A—female reproductive system—breast cancer	4.49e-05	0.0137	CbGeAlD
Paliperidone—ADRA2A—endocrine gland—breast cancer	4.47e-05	0.0136	CbGeAlD
Paliperidone—HTR2A—adrenal gland—breast cancer	4.38e-05	0.0134	CbGeAlD
Paliperidone—CYP3A4—female reproductive system—breast cancer	4.16e-05	0.0127	CbGeAlD
Paliperidone—CYP2D6—female reproductive system—breast cancer	4.09e-05	0.0125	CbGeAlD
Paliperidone—ADRA2C—lymph node—breast cancer	3.87e-05	0.0118	CbGeAlD
Paliperidone—HTR2A—endocrine gland—breast cancer	3.8e-05	0.0116	CbGeAlD
Paliperidone—CYP2D6—female gonad—breast cancer	3.72e-05	0.0114	CbGeAlD
Paliperidone—CYP3A4—endocrine gland—breast cancer	3.52e-05	0.0107	CbGeAlD
Paliperidone—CYP2D6—endocrine gland—breast cancer	3.46e-05	0.0106	CbGeAlD
Paliperidone—Oedema peripheral—Doxorubicin—breast cancer	3.41e-05	0.000126	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—breast cancer	3.41e-05	0.000126	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Docetaxel—breast cancer	3.4e-05	0.000126	CcSEcCtD
Paliperidone—Connective tissue disorder—Doxorubicin—breast cancer	3.4e-05	0.000126	CcSEcCtD
Paliperidone—Dyspnoea—Capecitabine—breast cancer	3.4e-05	0.000126	CcSEcCtD
Paliperidone—Fatigue—Docetaxel—breast cancer	3.4e-05	0.000126	CcSEcCtD
Paliperidone—Angiopathy—Epirubicin—breast cancer	3.4e-05	0.000125	CcSEcCtD
Paliperidone—Urethral disorder—Doxorubicin—breast cancer	3.39e-05	0.000125	CcSEcCtD
Paliperidone—Nausea—Mitoxantrone—breast cancer	3.39e-05	0.000125	CcSEcCtD
Paliperidone—Nausea—Irinotecan—breast cancer	3.39e-05	0.000125	CcSEcCtD
Paliperidone—Immune system disorder—Epirubicin—breast cancer	3.38e-05	0.000125	CcSEcCtD
Paliperidone—Mediastinal disorder—Epirubicin—breast cancer	3.37e-05	0.000125	CcSEcCtD
Paliperidone—Pain—Docetaxel—breast cancer	3.37e-05	0.000125	CcSEcCtD
Paliperidone—Constipation—Docetaxel—breast cancer	3.37e-05	0.000125	CcSEcCtD
Paliperidone—Back pain—Methotrexate—breast cancer	3.37e-05	0.000124	CcSEcCtD
Paliperidone—Dyspepsia—Capecitabine—breast cancer	3.36e-05	0.000124	CcSEcCtD
Paliperidone—Chills—Epirubicin—breast cancer	3.36e-05	0.000124	CcSEcCtD
Paliperidone—Asthenia—Paclitaxel—breast cancer	3.34e-05	0.000123	CcSEcCtD
Paliperidone—Decreased appetite—Capecitabine—breast cancer	3.32e-05	0.000123	CcSEcCtD
Paliperidone—Alopecia—Epirubicin—breast cancer	3.31e-05	0.000122	CcSEcCtD
Paliperidone—Nausea—Gemcitabine—breast cancer	3.3e-05	0.000122	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Capecitabine—breast cancer	3.29e-05	0.000122	CcSEcCtD
Paliperidone—Fatigue—Capecitabine—breast cancer	3.29e-05	0.000122	CcSEcCtD
Paliperidone—Pruritus—Paclitaxel—breast cancer	3.29e-05	0.000122	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—breast cancer	3.28e-05	0.000121	CcSEcCtD
Paliperidone—Mental disorder—Epirubicin—breast cancer	3.28e-05	0.000121	CcSEcCtD
Paliperidone—Pain—Capecitabine—breast cancer	3.26e-05	0.000121	CcSEcCtD
Paliperidone—Constipation—Capecitabine—breast cancer	3.26e-05	0.000121	CcSEcCtD
Paliperidone—Erythema—Epirubicin—breast cancer	3.26e-05	0.00012	CcSEcCtD
Paliperidone—Malnutrition—Epirubicin—breast cancer	3.26e-05	0.00012	CcSEcCtD
Paliperidone—Feeling abnormal—Docetaxel—breast cancer	3.25e-05	0.00012	CcSEcCtD
Paliperidone—Nausea—Fluorouracil—breast cancer	3.24e-05	0.00012	CcSEcCtD
Paliperidone—Eye disorder—Doxorubicin—breast cancer	3.24e-05	0.00012	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—breast cancer	3.23e-05	0.000119	CcSEcCtD
Paliperidone—Tinnitus—Doxorubicin—breast cancer	3.23e-05	0.000119	CcSEcCtD
Paliperidone—Gastrointestinal pain—Docetaxel—breast cancer	3.22e-05	0.000119	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—breast cancer	3.22e-05	0.000119	CcSEcCtD
Paliperidone—Flushing—Doxorubicin—breast cancer	3.21e-05	0.000119	CcSEcCtD
Paliperidone—Cardiac disorder—Doxorubicin—breast cancer	3.21e-05	0.000119	CcSEcCtD
Paliperidone—Flatulence—Epirubicin—breast cancer	3.21e-05	0.000119	CcSEcCtD
Paliperidone—Tension—Epirubicin—breast cancer	3.2e-05	0.000118	CcSEcCtD
Paliperidone—Dysgeusia—Epirubicin—breast cancer	3.19e-05	0.000118	CcSEcCtD
Paliperidone—Diarrhoea—Paclitaxel—breast cancer	3.18e-05	0.000118	CcSEcCtD
Paliperidone—Nervousness—Epirubicin—breast cancer	3.16e-05	0.000117	CcSEcCtD
Paliperidone—Back pain—Epirubicin—breast cancer	3.15e-05	0.000116	CcSEcCtD
Paliperidone—HRH1—lymph node—breast cancer	3.15e-05	0.00961	CbGeAlD
Paliperidone—Feeling abnormal—Capecitabine—breast cancer	3.14e-05	0.000116	CcSEcCtD
Paliperidone—Angiopathy—Doxorubicin—breast cancer	3.14e-05	0.000116	CcSEcCtD
Paliperidone—Malaise—Methotrexate—breast cancer	3.14e-05	0.000116	CcSEcCtD
Paliperidone—Muscle spasms—Epirubicin—breast cancer	3.13e-05	0.000116	CcSEcCtD
Paliperidone—Immune system disorder—Doxorubicin—breast cancer	3.13e-05	0.000116	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—breast cancer	3.13e-05	0.000116	CcSEcCtD
Paliperidone—Gastrointestinal pain—Capecitabine—breast cancer	3.12e-05	0.000115	CcSEcCtD
Paliperidone—Mediastinal disorder—Doxorubicin—breast cancer	3.12e-05	0.000115	CcSEcCtD
Paliperidone—Abdominal pain—Docetaxel—breast cancer	3.12e-05	0.000115	CcSEcCtD
Paliperidone—Body temperature increased—Docetaxel—breast cancer	3.12e-05	0.000115	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—breast cancer	3.12e-05	0.000115	CcSEcCtD
Paliperidone—Chills—Doxorubicin—breast cancer	3.11e-05	0.000115	CcSEcCtD
Paliperidone—ADRA2A—lymph node—breast cancer	3.09e-05	0.00944	CbGeAlD
Paliperidone—Dizziness—Paclitaxel—breast cancer	3.08e-05	0.000114	CcSEcCtD
Paliperidone—Vision blurred—Epirubicin—breast cancer	3.07e-05	0.000113	CcSEcCtD
Paliperidone—Alopecia—Doxorubicin—breast cancer	3.06e-05	0.000113	CcSEcCtD
Paliperidone—Cough—Methotrexate—breast cancer	3.04e-05	0.000112	CcSEcCtD
Paliperidone—Mental disorder—Doxorubicin—breast cancer	3.03e-05	0.000112	CcSEcCtD
Paliperidone—Urticaria—Capecitabine—breast cancer	3.03e-05	0.000112	CcSEcCtD
Paliperidone—Ill-defined disorder—Epirubicin—breast cancer	3.02e-05	0.000112	CcSEcCtD
Paliperidone—Abdominal pain—Capecitabine—breast cancer	3.02e-05	0.000111	CcSEcCtD
Paliperidone—Body temperature increased—Capecitabine—breast cancer	3.02e-05	0.000111	CcSEcCtD
Paliperidone—Convulsion—Methotrexate—breast cancer	3.02e-05	0.000111	CcSEcCtD
Paliperidone—Erythema—Doxorubicin—breast cancer	3.01e-05	0.000111	CcSEcCtD
Paliperidone—Malnutrition—Doxorubicin—breast cancer	3.01e-05	0.000111	CcSEcCtD
Paliperidone—Anaemia—Epirubicin—breast cancer	3.01e-05	0.000111	CcSEcCtD
Paliperidone—Agitation—Epirubicin—breast cancer	2.99e-05	0.000111	CcSEcCtD
Paliperidone—Flatulence—Doxorubicin—breast cancer	2.97e-05	0.00011	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—breast cancer	2.96e-05	0.000109	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—breast cancer	2.96e-05	0.000109	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—breast cancer	2.96e-05	0.000109	CcSEcCtD
Paliperidone—Tension—Doxorubicin—breast cancer	2.96e-05	0.000109	CcSEcCtD
Paliperidone—Vomiting—Paclitaxel—breast cancer	2.96e-05	0.000109	CcSEcCtD
Paliperidone—Dysgeusia—Doxorubicin—breast cancer	2.95e-05	0.000109	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.94e-05	0.000109	CcSEcCtD
Paliperidone—Malaise—Epirubicin—breast cancer	2.94e-05	0.000109	CcSEcCtD
Paliperidone—Rash—Paclitaxel—breast cancer	2.93e-05	0.000108	CcSEcCtD
Paliperidone—Dermatitis—Paclitaxel—breast cancer	2.93e-05	0.000108	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—breast cancer	2.93e-05	0.000108	CcSEcCtD
Paliperidone—Nervousness—Doxorubicin—breast cancer	2.93e-05	0.000108	CcSEcCtD
Paliperidone—Vertigo—Epirubicin—breast cancer	2.93e-05	0.000108	CcSEcCtD
Paliperidone—Syncope—Epirubicin—breast cancer	2.92e-05	0.000108	CcSEcCtD
Paliperidone—Leukopenia—Epirubicin—breast cancer	2.92e-05	0.000108	CcSEcCtD
Paliperidone—Back pain—Doxorubicin—breast cancer	2.92e-05	0.000108	CcSEcCtD
Paliperidone—Headache—Paclitaxel—breast cancer	2.91e-05	0.000108	CcSEcCtD
Paliperidone—Hypersensitivity—Docetaxel—breast cancer	2.9e-05	0.000107	CcSEcCtD
Paliperidone—Muscle spasms—Doxorubicin—breast cancer	2.9e-05	0.000107	CcSEcCtD
Paliperidone—Palpitations—Epirubicin—breast cancer	2.88e-05	0.000106	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—breast cancer	2.86e-05	0.000106	CcSEcCtD
Paliperidone—Loss of consciousness—Epirubicin—breast cancer	2.86e-05	0.000106	CcSEcCtD
Paliperidone—Cough—Epirubicin—breast cancer	2.84e-05	0.000105	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—breast cancer	2.84e-05	0.000105	CcSEcCtD
Paliperidone—Vision blurred—Doxorubicin—breast cancer	2.84e-05	0.000105	CcSEcCtD
Paliperidone—Asthenia—Docetaxel—breast cancer	2.83e-05	0.000104	CcSEcCtD
Paliperidone—Convulsion—Epirubicin—breast cancer	2.82e-05	0.000104	CcSEcCtD
Paliperidone—Infection—Methotrexate—breast cancer	2.82e-05	0.000104	CcSEcCtD
Paliperidone—Hypertension—Epirubicin—breast cancer	2.81e-05	0.000104	CcSEcCtD
Paliperidone—Hypersensitivity—Capecitabine—breast cancer	2.81e-05	0.000104	CcSEcCtD
Paliperidone—Ill-defined disorder—Doxorubicin—breast cancer	2.8e-05	0.000103	CcSEcCtD
Paliperidone—Pruritus—Docetaxel—breast cancer	2.79e-05	0.000103	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—breast cancer	2.79e-05	0.000103	CcSEcCtD
Paliperidone—Anaemia—Doxorubicin—breast cancer	2.79e-05	0.000103	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—breast cancer	2.78e-05	0.000103	CcSEcCtD
Paliperidone—Chest pain—Epirubicin—breast cancer	2.77e-05	0.000102	CcSEcCtD
Paliperidone—Arthralgia—Epirubicin—breast cancer	2.77e-05	0.000102	CcSEcCtD
Paliperidone—Myalgia—Epirubicin—breast cancer	2.77e-05	0.000102	CcSEcCtD
Paliperidone—Agitation—Doxorubicin—breast cancer	2.77e-05	0.000102	CcSEcCtD
Paliperidone—Anxiety—Epirubicin—breast cancer	2.76e-05	0.000102	CcSEcCtD
Paliperidone—Nausea—Paclitaxel—breast cancer	2.76e-05	0.000102	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—breast cancer	2.76e-05	0.000102	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.75e-05	0.000102	CcSEcCtD
Paliperidone—Discomfort—Epirubicin—breast cancer	2.74e-05	0.000101	CcSEcCtD
Paliperidone—Asthenia—Capecitabine—breast cancer	2.74e-05	0.000101	CcSEcCtD
Paliperidone—Malaise—Doxorubicin—breast cancer	2.72e-05	0.0001	CcSEcCtD
Paliperidone—Dry mouth—Epirubicin—breast cancer	2.71e-05	0.0001	CcSEcCtD
Paliperidone—Vertigo—Doxorubicin—breast cancer	2.71e-05	0.0001	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—breast cancer	2.71e-05	0.0001	CcSEcCtD
Paliperidone—Syncope—Doxorubicin—breast cancer	2.7e-05	9.99e-05	CcSEcCtD
Paliperidone—Pruritus—Capecitabine—breast cancer	2.7e-05	9.97e-05	CcSEcCtD
Paliperidone—Leukopenia—Doxorubicin—breast cancer	2.7e-05	9.97e-05	CcSEcCtD
Paliperidone—Diarrhoea—Docetaxel—breast cancer	2.7e-05	9.96e-05	CcSEcCtD
Paliperidone—Confusional state—Epirubicin—breast cancer	2.68e-05	9.9e-05	CcSEcCtD
Paliperidone—Palpitations—Doxorubicin—breast cancer	2.66e-05	9.84e-05	CcSEcCtD
Paliperidone—Oedema—Epirubicin—breast cancer	2.66e-05	9.82e-05	CcSEcCtD
Paliperidone—Anaphylactic shock—Epirubicin—breast cancer	2.66e-05	9.82e-05	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—breast cancer	2.65e-05	9.81e-05	CcSEcCtD
Paliperidone—Loss of consciousness—Doxorubicin—breast cancer	2.65e-05	9.79e-05	CcSEcCtD
Paliperidone—Infection—Epirubicin—breast cancer	2.64e-05	9.76e-05	CcSEcCtD
Paliperidone—Cough—Doxorubicin—breast cancer	2.63e-05	9.72e-05	CcSEcCtD
Paliperidone—Shock—Epirubicin—breast cancer	2.62e-05	9.66e-05	CcSEcCtD
Paliperidone—Convulsion—Doxorubicin—breast cancer	2.61e-05	9.65e-05	CcSEcCtD
Paliperidone—Diarrhoea—Capecitabine—breast cancer	2.61e-05	9.65e-05	CcSEcCtD
Paliperidone—Nervous system disorder—Epirubicin—breast cancer	2.61e-05	9.63e-05	CcSEcCtD
Paliperidone—Dizziness—Docetaxel—breast cancer	2.61e-05	9.63e-05	CcSEcCtD
Paliperidone—Thrombocytopenia—Epirubicin—breast cancer	2.6e-05	9.62e-05	CcSEcCtD
Paliperidone—Hypertension—Doxorubicin—breast cancer	2.6e-05	9.61e-05	CcSEcCtD
Paliperidone—Tachycardia—Epirubicin—breast cancer	2.59e-05	9.59e-05	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.59e-05	9.56e-05	CcSEcCtD
Paliperidone—Skin disorder—Epirubicin—breast cancer	2.58e-05	9.54e-05	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—breast cancer	2.57e-05	9.49e-05	CcSEcCtD
Paliperidone—Arthralgia—Doxorubicin—breast cancer	2.57e-05	9.48e-05	CcSEcCtD
Paliperidone—Chest pain—Doxorubicin—breast cancer	2.57e-05	9.48e-05	CcSEcCtD
Paliperidone—Myalgia—Doxorubicin—breast cancer	2.57e-05	9.48e-05	CcSEcCtD
Paliperidone—Anxiety—Doxorubicin—breast cancer	2.56e-05	9.45e-05	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—breast cancer	2.55e-05	9.42e-05	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.55e-05	9.41e-05	CcSEcCtD
Paliperidone—Discomfort—Doxorubicin—breast cancer	2.54e-05	9.37e-05	CcSEcCtD
Paliperidone—Anorexia—Epirubicin—breast cancer	2.53e-05	9.36e-05	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—breast cancer	2.53e-05	9.36e-05	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—breast cancer	2.53e-05	9.33e-05	CcSEcCtD
Paliperidone—Dizziness—Capecitabine—breast cancer	2.52e-05	9.32e-05	CcSEcCtD
Paliperidone—Dry mouth—Doxorubicin—breast cancer	2.51e-05	9.27e-05	CcSEcCtD
Paliperidone—Vomiting—Docetaxel—breast cancer	2.51e-05	9.26e-05	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—breast cancer	2.5e-05	9.24e-05	CcSEcCtD
Paliperidone—Rash—Docetaxel—breast cancer	2.49e-05	9.18e-05	CcSEcCtD
Paliperidone—Hypotension—Epirubicin—breast cancer	2.48e-05	9.18e-05	CcSEcCtD
Paliperidone—Dermatitis—Docetaxel—breast cancer	2.48e-05	9.17e-05	CcSEcCtD
Paliperidone—Confusional state—Doxorubicin—breast cancer	2.48e-05	9.16e-05	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—breast cancer	2.47e-05	9.12e-05	CcSEcCtD
Paliperidone—Headache—Docetaxel—breast cancer	2.47e-05	9.12e-05	CcSEcCtD
Paliperidone—Oedema—Doxorubicin—breast cancer	2.46e-05	9.09e-05	CcSEcCtD
Paliperidone—Anaphylactic shock—Doxorubicin—breast cancer	2.46e-05	9.09e-05	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—breast cancer	2.45e-05	9.06e-05	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—breast cancer	2.45e-05	9.05e-05	CcSEcCtD
Paliperidone—Infection—Doxorubicin—breast cancer	2.44e-05	9.03e-05	CcSEcCtD
Paliperidone—Pain—Methotrexate—breast cancer	2.43e-05	8.97e-05	CcSEcCtD
Paliperidone—Vomiting—Capecitabine—breast cancer	2.43e-05	8.96e-05	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.42e-05	8.95e-05	CcSEcCtD
Paliperidone—Shock—Doxorubicin—breast cancer	2.42e-05	8.94e-05	CcSEcCtD
Paliperidone—Nervous system disorder—Doxorubicin—breast cancer	2.41e-05	8.91e-05	CcSEcCtD
Paliperidone—Thrombocytopenia—Doxorubicin—breast cancer	2.41e-05	8.9e-05	CcSEcCtD
Paliperidone—Rash—Capecitabine—breast cancer	2.41e-05	8.89e-05	CcSEcCtD
Paliperidone—Insomnia—Epirubicin—breast cancer	2.4e-05	8.88e-05	CcSEcCtD
Paliperidone—Dermatitis—Capecitabine—breast cancer	2.4e-05	8.88e-05	CcSEcCtD
Paliperidone—Tachycardia—Doxorubicin—breast cancer	2.4e-05	8.87e-05	CcSEcCtD
Paliperidone—Headache—Capecitabine—breast cancer	2.39e-05	8.83e-05	CcSEcCtD
Paliperidone—Skin disorder—Doxorubicin—breast cancer	2.39e-05	8.83e-05	CcSEcCtD
Paliperidone—Paraesthesia—Epirubicin—breast cancer	2.39e-05	8.82e-05	CcSEcCtD
Paliperidone—Dyspnoea—Epirubicin—breast cancer	2.37e-05	8.76e-05	CcSEcCtD
Paliperidone—Somnolence—Epirubicin—breast cancer	2.36e-05	8.73e-05	CcSEcCtD
Paliperidone—Anorexia—Doxorubicin—breast cancer	2.34e-05	8.66e-05	CcSEcCtD
Paliperidone—Nausea—Docetaxel—breast cancer	2.34e-05	8.65e-05	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—breast cancer	2.34e-05	8.65e-05	CcSEcCtD
Paliperidone—Dyspepsia—Epirubicin—breast cancer	2.34e-05	8.65e-05	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methotrexate—breast cancer	2.32e-05	8.58e-05	CcSEcCtD
Paliperidone—Decreased appetite—Epirubicin—breast cancer	2.31e-05	8.54e-05	CcSEcCtD
Paliperidone—Hypotension—Doxorubicin—breast cancer	2.3e-05	8.49e-05	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Epirubicin—breast cancer	2.3e-05	8.48e-05	CcSEcCtD
Paliperidone—Fatigue—Epirubicin—breast cancer	2.29e-05	8.47e-05	CcSEcCtD
Paliperidone—Pain—Epirubicin—breast cancer	2.27e-05	8.4e-05	CcSEcCtD
Paliperidone—Constipation—Epirubicin—breast cancer	2.27e-05	8.4e-05	CcSEcCtD
Paliperidone—Nausea—Capecitabine—breast cancer	2.27e-05	8.37e-05	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—breast cancer	2.26e-05	8.34e-05	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—breast cancer	2.25e-05	8.3e-05	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—breast cancer	2.25e-05	8.3e-05	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.24e-05	8.28e-05	CcSEcCtD
Paliperidone—Insomnia—Doxorubicin—breast cancer	2.22e-05	8.22e-05	CcSEcCtD
Paliperidone—Paraesthesia—Doxorubicin—breast cancer	2.21e-05	8.16e-05	CcSEcCtD
Paliperidone—Dyspnoea—Doxorubicin—breast cancer	2.19e-05	8.1e-05	CcSEcCtD
Paliperidone—Feeling abnormal—Epirubicin—breast cancer	2.19e-05	8.09e-05	CcSEcCtD
Paliperidone—Somnolence—Doxorubicin—breast cancer	2.19e-05	8.08e-05	CcSEcCtD
Paliperidone—Gastrointestinal pain—Epirubicin—breast cancer	2.17e-05	8.03e-05	CcSEcCtD
Paliperidone—Dyspepsia—Doxorubicin—breast cancer	2.17e-05	8e-05	CcSEcCtD
Paliperidone—Decreased appetite—Doxorubicin—breast cancer	2.14e-05	7.9e-05	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Doxorubicin—breast cancer	2.12e-05	7.85e-05	CcSEcCtD
Paliperidone—Fatigue—Doxorubicin—breast cancer	2.12e-05	7.83e-05	CcSEcCtD
Paliperidone—Urticaria—Epirubicin—breast cancer	2.11e-05	7.8e-05	CcSEcCtD
Paliperidone—Constipation—Doxorubicin—breast cancer	2.1e-05	7.77e-05	CcSEcCtD
Paliperidone—Pain—Doxorubicin—breast cancer	2.1e-05	7.77e-05	CcSEcCtD
Paliperidone—Abdominal pain—Epirubicin—breast cancer	2.1e-05	7.76e-05	CcSEcCtD
Paliperidone—Body temperature increased—Epirubicin—breast cancer	2.1e-05	7.76e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—breast cancer	2.09e-05	7.73e-05	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—breast cancer	2.04e-05	7.53e-05	CcSEcCtD
Paliperidone—Feeling abnormal—Doxorubicin—breast cancer	2.03e-05	7.49e-05	CcSEcCtD
Paliperidone—Gastrointestinal pain—Doxorubicin—breast cancer	2.01e-05	7.43e-05	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—breast cancer	2.01e-05	7.43e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Epirubicin—breast cancer	1.96e-05	7.24e-05	CcSEcCtD
Paliperidone—Urticaria—Doxorubicin—breast cancer	1.95e-05	7.22e-05	CcSEcCtD
Paliperidone—Abdominal pain—Doxorubicin—breast cancer	1.94e-05	7.18e-05	CcSEcCtD
Paliperidone—Body temperature increased—Doxorubicin—breast cancer	1.94e-05	7.18e-05	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—breast cancer	1.94e-05	7.18e-05	CcSEcCtD
Paliperidone—Asthenia—Epirubicin—breast cancer	1.91e-05	7.05e-05	CcSEcCtD
Paliperidone—Pruritus—Epirubicin—breast cancer	1.88e-05	6.95e-05	CcSEcCtD
Paliperidone—Dizziness—Methotrexate—breast cancer	1.88e-05	6.94e-05	CcSEcCtD
Paliperidone—Diarrhoea—Epirubicin—breast cancer	1.82e-05	6.72e-05	CcSEcCtD
Paliperidone—Hypersensitivity—Doxorubicin—breast cancer	1.81e-05	6.7e-05	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—breast cancer	1.81e-05	6.67e-05	CcSEcCtD
Paliperidone—Rash—Methotrexate—breast cancer	1.79e-05	6.62e-05	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—breast cancer	1.79e-05	6.61e-05	CcSEcCtD
Paliperidone—Headache—Methotrexate—breast cancer	1.78e-05	6.57e-05	CcSEcCtD
Paliperidone—Asthenia—Doxorubicin—breast cancer	1.76e-05	6.52e-05	CcSEcCtD
Paliperidone—Dizziness—Epirubicin—breast cancer	1.76e-05	6.49e-05	CcSEcCtD
Paliperidone—Pruritus—Doxorubicin—breast cancer	1.74e-05	6.43e-05	CcSEcCtD
Paliperidone—Vomiting—Epirubicin—breast cancer	1.69e-05	6.24e-05	CcSEcCtD
Paliperidone—Nausea—Methotrexate—breast cancer	1.69e-05	6.23e-05	CcSEcCtD
Paliperidone—Diarrhoea—Doxorubicin—breast cancer	1.68e-05	6.22e-05	CcSEcCtD
Paliperidone—Rash—Epirubicin—breast cancer	1.68e-05	6.19e-05	CcSEcCtD
Paliperidone—Dermatitis—Epirubicin—breast cancer	1.67e-05	6.19e-05	CcSEcCtD
Paliperidone—Headache—Epirubicin—breast cancer	1.67e-05	6.15e-05	CcSEcCtD
Paliperidone—Dizziness—Doxorubicin—breast cancer	1.63e-05	6.01e-05	CcSEcCtD
Paliperidone—Nausea—Epirubicin—breast cancer	1.58e-05	5.83e-05	CcSEcCtD
Paliperidone—Vomiting—Doxorubicin—breast cancer	1.56e-05	5.78e-05	CcSEcCtD
Paliperidone—Rash—Doxorubicin—breast cancer	1.55e-05	5.73e-05	CcSEcCtD
Paliperidone—Dermatitis—Doxorubicin—breast cancer	1.55e-05	5.72e-05	CcSEcCtD
Paliperidone—Headache—Doxorubicin—breast cancer	1.54e-05	5.69e-05	CcSEcCtD
Paliperidone—Nausea—Doxorubicin—breast cancer	1.46e-05	5.4e-05	CcSEcCtD
Paliperidone—HTR2C—Signaling Pathways—SRC—breast cancer	2.32e-06	2.06e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ERBB2—breast cancer	2.31e-06	2.06e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CASP3—breast cancer	2.31e-06	2.06e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	2.31e-06	2.06e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2—breast cancer	2.3e-06	2.05e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CASP3—breast cancer	2.3e-06	2.05e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2—breast cancer	2.3e-06	2.05e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—breast cancer	2.3e-06	2.05e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—breast cancer	2.29e-06	2.04e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—breast cancer	2.29e-06	2.04e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PIK3CA—breast cancer	2.29e-06	2.04e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCND1—breast cancer	2.28e-06	2.04e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MTOR—breast cancer	2.28e-06	2.04e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	2.28e-06	2.04e-05	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	2.28e-06	2.03e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—JUN—breast cancer	2.28e-06	2.03e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—breast cancer	2.27e-06	2.02e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CTNNB1—breast cancer	2.26e-06	2.02e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CASP3—breast cancer	2.26e-06	2.01e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2—breast cancer	2.26e-06	2.01e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—breast cancer	2.25e-06	2.01e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SRC—breast cancer	2.25e-06	2.01e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—breast cancer	2.25e-06	2e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCND1—breast cancer	2.25e-06	2e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—breast cancer	2.24e-06	2e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—STAT3—breast cancer	2.24e-06	2e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—JUN—breast cancer	2.24e-06	2e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCND1—breast cancer	2.24e-06	2e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—KRAS—breast cancer	2.24e-06	2e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—JUN—breast cancer	2.24e-06	1.99e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—COMT—breast cancer	2.23e-06	1.99e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—STAT3—breast cancer	2.23e-06	1.99e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CTNNB1—breast cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GSTP1—breast cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MAPK3—breast cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SRC—breast cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—breast cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—breast cancer	2.21e-06	1.97e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—KRAS—breast cancer	2.21e-06	1.97e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CDKN1A—breast cancer	2.21e-06	1.97e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PTEN—breast cancer	2.2e-06	1.96e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.2e-06	1.96e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—HRAS—breast cancer	2.2e-06	1.96e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—JUN—breast cancer	2.19e-06	1.96e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HMOX1—breast cancer	2.19e-06	1.96e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.19e-06	1.96e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—breast cancer	2.19e-06	1.96e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ITPR1—breast cancer	2.19e-06	1.95e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—breast cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—breast cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CDKN1A—breast cancer	2.17e-06	1.94e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—STAT3—breast cancer	2.17e-06	1.94e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.17e-06	1.93e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PTEN—breast cancer	2.17e-06	1.93e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PTEN—breast cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTEN—breast cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MYC—breast cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—breast cancer	2.16e-06	1.92e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK8—breast cancer	2.16e-06	1.92e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—breast cancer	2.16e-06	1.92e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—HRAS—breast cancer	2.15e-06	1.92e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—breast cancer	2.15e-06	1.92e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MAPK3—breast cancer	2.14e-06	1.91e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.14e-06	1.91e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—STAT3—breast cancer	2.14e-06	1.91e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.14e-06	1.9e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MAPK3—breast cancer	2.13e-06	1.9e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.13e-06	1.9e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK8—breast cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK8—breast cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—HRAS—breast cancer	2.12e-06	1.89e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—breast cancer	2.11e-06	1.89e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EGFR—breast cancer	2.11e-06	1.88e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—breast cancer	2.11e-06	1.88e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ABCB1—breast cancer	2.11e-06	1.88e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—breast cancer	2.1e-06	1.87e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CASP3—breast cancer	2.1e-06	1.87e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2—breast cancer	2.1e-06	1.87e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—breast cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MYC—breast cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—breast cancer	2.08e-06	1.86e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK8—breast cancer	2.08e-06	1.85e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MAPK3—breast cancer	2.07e-06	1.85e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MYC—breast cancer	2.07e-06	1.85e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—breast cancer	2.07e-06	1.85e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—breast cancer	2.07e-06	1.85e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TYMS—breast cancer	2.07e-06	1.84e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PIK3CA—breast cancer	2.06e-06	1.84e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—breast cancer	2.06e-06	1.84e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PIK3CA—breast cancer	2.05e-06	1.83e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GSTM1—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NCOR1—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCND1—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SRC—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MAPK3—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CD—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EGFR—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—JUN—breast cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PIK3CA—breast cancer	2.03e-06	1.81e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EGFR—breast cancer	2.03e-06	1.81e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—breast cancer	2.02e-06	1.81e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	2.02e-06	1.8e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MYC—breast cancer	2.02e-06	1.8e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—breast cancer	2.01e-06	1.8e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—breast cancer	2.01e-06	1.8e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SRC—breast cancer	2.01e-06	1.79e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SRC—breast cancer	2.01e-06	1.79e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—KRAS—breast cancer	2e-06	1.78e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—breast cancer	1.99e-06	1.78e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—breast cancer	1.99e-06	1.77e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MYC—breast cancer	1.99e-06	1.77e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.98e-06	1.77e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.98e-06	1.77e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.97e-06	1.76e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.97e-06	1.76e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—STAT3—breast cancer	1.97e-06	1.76e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SRC—breast cancer	1.97e-06	1.76e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—breast cancer	1.97e-06	1.75e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.96e-06	1.75e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GPX1—breast cancer	1.96e-06	1.75e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—breast cancer	1.95e-06	1.74e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.94e-06	1.73e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—STAT3—breast cancer	1.94e-06	1.73e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—breast cancer	1.94e-06	1.73e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.94e-06	1.73e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—STAT3—breast cancer	1.93e-06	1.73e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.93e-06	1.72e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—breast cancer	1.93e-06	1.72e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—KRAS—breast cancer	1.93e-06	1.72e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.92e-06	1.72e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ERCC2—breast cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—KRAS—breast cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—HRAS—breast cancer	1.9e-06	1.7e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—breast cancer	1.9e-06	1.69e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.9e-06	1.69e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK3—breast cancer	1.88e-06	1.68e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—HRAS—breast cancer	1.88e-06	1.68e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—breast cancer	1.87e-06	1.67e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.86e-06	1.66e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.85e-06	1.65e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK3—breast cancer	1.85e-06	1.65e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.84e-06	1.64e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.83e-06	1.64e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MYC—breast cancer	1.83e-06	1.63e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SRC—breast cancer	1.83e-06	1.63e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—breast cancer	1.83e-06	1.63e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—breast cancer	1.82e-06	1.63e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.81e-06	1.62e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—breast cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MYC—breast cancer	1.8e-06	1.61e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—breast cancer	1.8e-06	1.6e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MYC—breast cancer	1.8e-06	1.6e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.8e-06	1.6e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—breast cancer	1.79e-06	1.6e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EGFR—breast cancer	1.79e-06	1.6e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.78e-06	1.59e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.78e-06	1.59e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—breast cancer	1.77e-06	1.58e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PIK3CA—breast cancer	1.77e-06	1.58e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MYC—breast cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—breast cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EGFR—breast cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EGFR—breast cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.73e-06	1.54e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.71e-06	1.53e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—breast cancer	1.71e-06	1.53e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—breast cancer	1.7e-06	1.52e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.7e-06	1.51e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—KRAS—breast cancer	1.69e-06	1.51e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.69e-06	1.5e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.69e-06	1.5e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—breast cancer	1.68e-06	1.5e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—breast cancer	1.67e-06	1.49e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CAV1—breast cancer	1.67e-06	1.49e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—KRAS—breast cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PIK3CA—breast cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—KRAS—breast cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—breast cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—breast cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MYC—breast cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HRAS—breast cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—breast cancer	1.63e-06	1.45e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.63e-06	1.45e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HRAS—breast cancer	1.63e-06	1.45e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—breast cancer	1.62e-06	1.45e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.6e-06	1.43e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.58e-06	1.41e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—breast cancer	1.57e-06	1.4e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.56e-06	1.39e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—breast cancer	1.56e-06	1.39e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.55e-06	1.39e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTEN—breast cancer	1.54e-06	1.37e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PIK3CA—breast cancer	1.53e-06	1.36e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.53e-06	1.36e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PIK3CA—breast cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.52e-06	1.35e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—breast cancer	1.52e-06	1.35e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.51e-06	1.35e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—breast cancer	1.5e-06	1.34e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.5e-06	1.34e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.5e-06	1.34e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—breast cancer	1.49e-06	1.33e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—breast cancer	1.48e-06	1.32e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—breast cancer	1.48e-06	1.32e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—breast cancer	1.45e-06	1.29e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—breast cancer	1.45e-06	1.29e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—breast cancer	1.44e-06	1.28e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HRAS—breast cancer	1.44e-06	1.28e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—HRAS—breast cancer	1.41e-06	1.26e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HRAS—breast cancer	1.41e-06	1.26e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—breast cancer	1.4e-06	1.25e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.39e-06	1.24e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.39e-06	1.24e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.38e-06	1.23e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—breast cancer	1.38e-06	1.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—breast cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—breast cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—breast cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—breast cancer	1.35e-06	1.2e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CD—breast cancer	1.33e-06	1.19e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—breast cancer	1.33e-06	1.18e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—breast cancer	1.32e-06	1.17e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.29e-06	1.15e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—breast cancer	1.27e-06	1.13e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—breast cancer	1.26e-06	1.12e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—breast cancer	1.25e-06	1.11e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—breast cancer	1.25e-06	1.11e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—breast cancer	1.25e-06	1.11e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—breast cancer	1.23e-06	1.1e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.22e-06	1.09e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.16e-06	1.04e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—breast cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.14e-06	1.01e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CA—breast cancer	1.08e-06	9.67e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTEN—breast cancer	1e-06	8.96e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—breast cancer	8.86e-07	7.9e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CA—breast cancer	7.09e-07	6.32e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—breast cancer	5.79e-07	5.16e-06	CbGpPWpGaD
